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Short-Term Assays
by Raymond W. Tennant,* Judson W. Spalding,* Stanley
Stasiewicz,* William D. Caspary,* James M. Mason,* and
Michael A. Resnick*
The results of a recent comprehensive evaluation of the relationship between four measures of in vitro
genetic toxicity and the capacity of the chemicals to induce neoplasia in rodents carry some important
implications. The results showed that while the Salmonella mutagenesis assay detected only about half
ofthe carcinogens as mutagens, the other three in vitro assays (mutagenesis in MOLY cells or induction
of aberrations or SCEs in CHO cells) did not complement Salmonella since they failed to effectively
discriminate between the carcinogens and noncarcinogens found negative in the Salmonella assay. The
specificity of the Salmonella assay for this group of 73 chemicals was relatively high (only 4 of 29 non-
carcinogens were positive). Therefore, we have begun to evaluate in vivo genetic toxicity assays for their
ability to complement Salmonella in the identification ofcarcinogens.
Introduction and Design of Study
Long-tern studies in rodents are the principal means
by which potential human carcinogens are identified.
The duration, costs, and concerns over the use of ani-
mals have been major problems associated with these
rodent studies, and these concerns have provided the
motivation to search for other experimental methods.
The observed association between the ability of chem-
icals to induce both mutations and tumors served to
promote development of the discipline of genetic toxi-
cology(1-5). Inthebroad sense, invitrogenetictoxicity
may be indicative of a chemical's capacity to heritably
alter cellular phenotypes by any one of a number of
potential mechanisms. A number ofgenetic toxicity as-
says have been used to identify chemicals that induce
either gene orchromosomalmutations, orothereffects,
via direct interaction with DNA. Extensive efforts by
the Environmental Protection Agency (EPA) to eval-
uate the capability ofgenetic toxicity assays to predict
potential carcinogenicity (6) revealed two majorimped-
imentsto aclearinterpretation; first, insufficientresults
for chemicals that are noncarcinogens (7); and second,
insufficient numbers ofcarcinogens and noncarcinogens
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that have been tested adequately in more than one or
two in vitro genetic toxicity assays.
Inorderto addresstheseinadequaciesandtodevelop
adatabasethatwasamenabletosystematicevaluation,
the NationalToxicology Program (NTP)initiated apro-
jecttoprovidegenetictoxicityresultsforchemicalsthat
were well characterized in rodents for carcinogenicity
or noncarcinogenicity. Detailed results of this evalua-
tion have been reported (8), and only certain aspects
willbe emphasized in thisreport. Thechemicals orsub-
stances selected for evaluation were chosen strictly be-
cause they had been assayed for carcinogenicity in ro-
dents under the aegis of the NTP (9). In order to be
included, the carcinogenicity studies must have been of
2-year duration, includingboth rats and mice, and com-
pleted between December 1976 and January 1985. In-
itially, 83 chemicals were selected by these criteria;
however, some substances tested during this period
such as gilsonite, guar gum, agar, gum acacia, propyl-
ene, etc., could not be tested adequately in vitro due
totheirphysicalstateorotherreasons, andwere, there-
fore, excluded from further consideration. Our evalu-
ations were made usingthe 73 chemicals listed in Table
1.
The in vitro and in vivo assays that provided genetic
toxicity patterns were performed on chemicals, under
code, in a number oflaboratories. The assay protocolsTENNANTETAL.
Table 1. Rodent carcinogenicity and S1TT results for 73 chemicals.
Carcinogenicitya Short-term testsb
Chemical MR FR MM FM SAL MOLY ABS SCE
Benzene
3-Chloro-2-methylpropene
Di (2-ethylhexyl) phthalate
1,2-Dibromo-3-chloropropane
1,2-Dibromoethane
Diglycidyl resorcinol ether
Ethyl acrylate
4,4'-Methylenedianiline 2HCl
4,4'-Oxydianiline
Polybrominated biphenyl mixture
Propylene oxide
2,3,7,8-Tetrachlorodibenzo-p-dioxin
1,3-Dichloropropene
Cinnamyl anthranilate
HC Blue 1
Reserpine
Selenium sulfide
2,4- and 2,6-Toluene diisocyanate
Allyl isovalerate
Benzyl acetate
bis (2-Chloro-1-methylethyl) ether
C.1. Disperse Yellow 3
C.I. Solvent Yellow 14
Cytembena
1,2-Dichloropropane
2,6-Dichloro-p-phenylenedianmine
Di(2-ethylhexyl) adipate
Dimethyl morpholinophosphoramidate
Pentachloroethane
1,1,1,2-tetrachloroethane
Trichloroethylene
Zearalenone
Allyl isothiocyanate
1i-Aminoundecanoic acid
2-Biphenylamine HCl
Butyl benzyl phthalate
Chlorodibromomethane
D & C Red 9
Dimethyl hydrogen phosphite
Isophorone
Melamine
Monuron
Tris(2-ethylhexyl)phosphate
Ziram
L-Ascorbic acid
Benzoin
Bisphenol A
C.I. Acid Orange 10
C.I. Acid Red 14
C.1. Acid Yellow 73
Caprolactam
Chlorobenzene
2-Chloroethanol
Diallyl phthalate
1,2-Dichlorobenzene
Dimethyl terephthalate
Ethoxylated dodecyl alcohol
Eugenol
FD & C Yellow No. 6
Geranyl acetate
Hamamelis water (witch hazel)
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Table 1. Continued
Carcinogenicity' Short-term testsb
Chemical MR FR MM FM SAL MOLY ABS SCE
HC Blue 2 - - - - +1+ +/0 -1- +/+
8-hydroxyquinoline - - - - -1+ +/0 -1+ +1+
Malaoxon - - - - -1- +/0 -I- +1+
D-Mannitol - - - - -/- -/- -/- -I-
DL-Menthol - - - - -/ - -/- -/- -/-
Phenol - - - - -1- -1+ -/+ +/+
Propyl gallate E - E - -/- +/0 +/- +/+
Sodium (2-ethylhexyl) alcohol sulfate - - - E -/- -1- _/ _/
Stannous chloride E - - - -1- -/- +/+ +/+
Sulfisoxazole - - - - -1- +/0 -1- +1+
Titanium dioxide - - - - -/- -/- -/- -/-
2,6-Toluenediamine 2HC1 - - - - -1+ +/0 +1- +1+
'MR, male rat; FR, female rat; MM, male mouse; FM, female mouse; E, equivocal; I, incomplete.
b(-/- ) Activity without S9/activity with S9; (/0) assay not performed.
for each of the four in vitro assay systems had been
developed previously (10-12) in order to ensure intra-
and interlaboratory reproducibility and subjected to
validation using chemicals tested under code in order
to ensure objective results (10-13). Assay protocols for
the other short-term tests (STT) (Table 2) inwhich sub-
sets of the 73 chemicals were tested have been devel-
oped to achieve similar standards ofperformance. Ali-
quots of the 73 chemicals were shipped from a central
repository, under code, to the testing laboratories.
Where it was possible, the same chemical lot that was
used in the rodent carcinogenicity studies was also
tested by the laboratories conducting the genetic tox-
icityassays. Thecriteriathatdefine anacceptable assay
have beenreportedpreviously foreachtest system (10-
13). Conclusions regarding the rodent carcinogenicity
ofthe chemicals weretakendirectlyfromthe NTPtech-
nical reports. The NTP currently uses a "categories-of-
evidence" scheme in which, for each sex/species group,
the carcinogenic response is classified into one of five
categories. There are two categories of positive re-
sponse ("some" or "clear"), one forequivocalresponses,
a negative category, and one category for studies that
are inadequate for evaluation. For the purpose of this
evaluation, chemicals that exhibited equivocal activity
in animal studies were included in the category ofnon-
carcinogens. Chemicals that showed equivocal activity
in the STT were also included in the negative category.
Rodent Carcinogenicity Results
The tumorigenicity patterns for the 44 carcinogens
(shown in Table 1) are quite variable in sex, species,
site and frequency, and include 12 chemicals that were
positiveinonlyoneofthefoursex/speciescombinations.
Twenty ofthe substances were judged to demonstrate
no evidence of carcinogenicity, and nine of the studies
werejudged equivocal. Each ofthe studies included an
equalnumber(50) oftreated andvehiclecontrolanimals
ineachsex/species group. Thecontrolanimals werealso
subject to complete postmortem examination. The re-
sults of the control group evaluations have been com-
piled to establish the spontaneous tumor incidence pat-
terns for each sex/species (14).
The most frequent sites oftumor induction were the
liver (24/44 chemicals), lung (8 chemicals), forestomach
(6chemicals), thyroid (5chemicals), andkidney(2chem-
icals) (8). Theliver, lung, andthyroidshowspontaneous
tumors at frequencies of 10 to 30% in untreated control
groups (called common tumors), whereas spontaneous
tumors are rarely seen in the forestomach or kidney
(uncommon tumors). Liver tumors were the only tu-
mors induced by 12 carcinogens, 1 of these produced
liver tumors in rats only, 8 in mice only, 1 in at least
one sex of both species, and 2 chemicals induced only
liver tumors in all four sex/species groups. Nine chem-
icalsinduced livertumorsinadditiontocommontumors
at other sites; 4 chemicals induced liver tumors in com-
bination with uncommon tumors in at least one other
site. Nine ofthe rodent carcinogens that did not induce
liver tumors induced common tumors at other organ
sites.
Five chemicals induced only uncommon tumors, 3 of
which(administeredbygavage)inducedonlypapillomas
and/or carcinomas of the forestomach in both sex/spe-
cies. Endocrine tumors, e.g., follicular cell tumors of
the thyroid, adrenal gland, pancreatic ascinar cells,
pheochromocytomas of the pituitary, were induced by
9 chemicals. Five ofthese induced thyroid follicular cell
adenomas or carcinomas.
The sex/species distribution oftumors inducedbythe
44 carcinogens revealed that 18 chemicals induced tu-
mors in at least one sex ofboth species, and 12 ofthese
induced tumors in both sexes ofboth species. Eight of
these 12 trans-sex/species carcinogens induced tumors
at multiple sites in at least one sex/species. Also, 7 of
the trans-sex/species carcinogens induced uncommon
tumors, while 2 induced tumors only in the liver.
Twenty-four ofthe 44 chemicals induced tumors in only
one species (12 each in rats or mice). Eight (ofthe 12)
induced tumors in onlymale rats, butnone ofthe chem-
icalsinduced tumorsonlyinmalemice, andonly 1 chem-
icalinduced tumorsonlyinthefemalerat. Livertumors
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Table 2. STT results for selected chemicals.
In vivol
DL In vivo In vivo in vitro In vitro
Chemical (SLRL) ABS SCE UDS UDS BALB/c SHE SHE/SA7 Rat RLV
Allyl isothiocyanate
Allyl isovalerate
11-Aminoudecanoic acid
L-Ascorbic acid
Benzene
Benzoin
Benzyl acetate
2-Biphenylamine HCl
Bis(2-chloro-1-methylethyl) ether
Bisphenol A
Butyl benzyl phthalate
C.I. Acid Orange 10
C.I. Aeid Yellow 73
C.I. Disperse Yellow 3
C.I. Solvent Yellow 14
Caprolactam
Chlorodibromomethane
2-Chloroethanol
Cinnamyl anthranilate
Cytembena
D & C Red 9
Di(2-ethylhexyl) adipate
Di(2-ethylhexyl) phthalate
Diallyl phthalate
1,2-Dibromo-3-chloropropane
1,2-Dibromoethane
2,6-Dichloro-p-phenylenediamine
1,2-Dichlorobenzene
1,2-Dichloropropane
1,3-Dichloropropene
Diglycidyl resorcinol ether
Dimethyl hydrogen phosphite
Dimethyl morpholinophosphoramidate
Ethyl acrylate
Eugenol
FD & C Yellow No. 6
Geranyl acetate
Hamamelis water (witch hazel)
HC Blue 1
HC Blue 2
8-Hydroxyquinoline
Isophorone
D-Mannitol
Melamine
4,4-Methylenedianiline 2HCl
Monuron
4,4'-Oxydianiline
Pentachloroethane
Phenol
Polybrominated biphenyl mixture
Reserpine
Selenium sulfide
Sodium (2-ethylhexyl)alcohol sulfate
Stannous chloride
Sulfisoxazole
2,3,7,8-Tetrachlorodibenzo-p-dioxin
Titanium dioxide
2,4- and 2,6-Toluene diisocyanate
2,6-Toluenediamine 2HCl
Trichloroethylene
Tris(2-ethylhexyl) phosphate
Zearalenone
Ziram
aE, equivocal
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were the only tumors induced by 8 ofthe 12 chemicals
that were carcinogenic only in mice.
Some sites oftumor induction are related to route of
exposure (e.g., nasal or glossal tumors were seen only
in inhalation studies, and forestomach tumors only in
gavage studies). The 3 chemicals administered by in-
halation (1,2-dibromo-3-chloropropane, 1,2-dibromo-
ethane andpropyleneoxide) weretumorigenicin allfour
sex/species groups. Thethyroid or urinarybladder were
the only tumor sites for four of the chemicals inducing
tumors in a single sex of one species.
Evaluation of STT
The 73 chemicals in this evaluation were tested in
each of the four principal in vitro assay systems; i.e.,
Salmonella/microsome mutagenicity assay (SAL);
mouse L5178Y lymphoma TK+- forward mutation as-
say (MOLY); chromosome aberrations assay (ABS) in
Chinese hamster ovary (CHO) cells; and the assay for
sister chromatid exchange (SCE) in CHO cells. These
assays arerepresentative ofthemostwidelyusedmeth-
ods for characterizing mutagenicity and clastogenicity.
With the exception ofthe MOLY assay, chemicals were
routinely tested in these four end points with and with-
out Aroclor 1254-induced rodent liver S9 preparations.
If a chemical exhibited activity in the MOLY assay in
the absence of S9, it was usually not tested with S9.
Subsets of the 73 chemicals were also evaluated in
several other STTs: in the in vitro unscheduled DNA
synthesis (UDS) in rat hepatocytes assay; in four in
vitro mammalian cell transformation systems (Table 2);
in the in vivo sex-linked recessive lethal mutagenicity
assay in Drosophila; in the in vivo-in vitro unscheduled
DNA synthesis (UDS) and scheduled DNA synthesis
(S-phase) assays in rodent hepatocytes; and in the in
vivo cytogenetics assays for chromosome aberrations
(ABS) and sister chromatid exchanges (SCE) in mouse
bone marrow.
Forthe purpose ofcalculating sensitivity, specificity,
positive and negative predictivity, and overall concord-
ance values (Table 3), an equivocal response in the
short-term tests was considered to be negative.
Mutagenicity in Salmonella typhimurium
Chemicals were evaluated in four to five strains of
Salmonella typhimurium using microsomal (S9) frac-
tions from rat or hamster livers as the exogenous met-
abolic activation system. The assay protocol and the
criteria for evaluating responses have been published
elsewhere (10). Clear evidence ofmutagenicity is indi-
cated by a reproducible, dose-related increase in the
mutantyield fromthe chemical-treated groupcompared
tothe solvent control groupin any one Salmonella strain
with or without exogenous metabolic activation.
Twenty-four of the 73 chemicals were mutagenic in
Salmonella, and 22/24 were positive in two or more
strains. While the sensitivity of the Salmonella assay
was low (45%) (Table 3), only 20 of the 44 carcinogens
Table 3. Characteristics offour STT for predicting
carcinogenicity.
SAL MOLY ABS SCE
+ - + - + - + -
Rodent
+ 20 24 31 13 24 20 32 12
4 25 16 13 9 20 16 13
Sensitivitya 45 70 55 73
Specificityb 86 45 69 45
Positive predictivityc 83 66 73 67
Negative predictivityd 51 50 50 52
Concordancee 62 60 60 62
aPercent ofcarcinogens yielding a positive SIT result.
bPercent ofnoncarcinogens yielding a positive STT result.
'Percent of SIT positives that are carcinogens.
dPercent of SIT positives that are noncarcinogens.
ePercent of qualitative agreements between STT and rodent car-
cinogenicity test results.
were detected, the positive predictivity was high; 20 of
the 24 chemicals mutagenic in Salmonella were rodent
carcinogens. Only 4 of the 12 chemicals that induced
onlylivertumorsweremutagenicinSalmonella, aswere
4 of the 12 chemicals inducing tumors in a single sex/
species. Twelve ofthe24 Salmonellamutagensrequired
metabolic activation in order to demonstrate a positive
effect.
The overall concordance of the mutagenic response
in any Salmonella strain with the rodent carcinogenesis
response is 62% (Table 3). However, the agreement
between mutagenicity in Salmonella and tumorigenesis
in any one of the four sex/species (i.e., the positive
predictivity of the assay) is 83%. These results show
that mutagenicity in Salmonella, obtained under the
protocols used in this study and evaluated according to
the stated criteria, indicates a high probability, though
not a certainty, for tumorigenicity in rodents. Con-
versely, the absence of a mutagenic response in any of
the Salmonella strains is not predictive of nontumori-
genicity.
Mutagenicity in Mouse Lymphoma
(L5178Y) Cells (MOLY)
Ofthe 44 carcinogens, 31 (sensitivity = 70%) (Table
3) were positive in the MOLY assay based upon the
published evaluation criteria (12,13). However, the as-
say also detected mutagenic activity in 16 (55%) ofthe
29noncarcinogenic orequivocal substances. Thirteen of
thecarcinogens and 13noncarcinogensexhibitednomu-
tagenic activity in MOLY cells. The range of active
doses varied from 0.0625 mg/mL for ziram to 1700 mg/
mL for dimethyl hydrogen phosphate, but the lowest
positive dose (LPD) did not show anyrelationship with
the LPD for carcinogenicity in rodents or sex/species
distribution of carcinogenic effects. There was a total
of47 (ofthe 73) chemicals that showed a positive effect
inMOLYcells;theoverallconcordanceoftheassaywith
carcinogenicity was 60% (Table2). Incomparisonto the
Salmonella mutagenesis results, all but 1 (D&C Red 9)
of the 24 chemicals mutagenic in Salmonella were mu-
91TENNANT ETAL.
tagenic in MOLY cells. In addition, positive responses
were induced in MOLY cells by 24 chemicals (12 car-
cinogens) that were not mutagenic in the Salmonella
assay (Table 2). Thus, although the results reflect a
higher sensitivity (70%) than that of the SAL assay,
the specificity ofthe MOLY assay was only 45% (Table
3) (8). These and other results (8) suggest that the
MOLY assay cannot serve in a complementary role to
the Salmonella assay. Since the specificity ofthe assay
indicates ahigh rate offalse positive results inthis data
set, some additional studies are necessary to determine
if chemicals that show a Salmonella negative, mouse
lymphoma positive result possess intrinsic mutagenic
potential not detected in the Salmonella assay or
whetherthese areidiosyncraticresponses ofthe MOLY
cells to some other properties of the chemicals.
Chromosomal Aberrations (ABS) and
Sister Chromatid Exchange (SCE)
Induction in Chinese Hamster Ovary
(CHO) Cells
Chromosomal aberrations were induced by 33/73
chemicals (24/44 carcinogens and 9/29 noncarcinogens).
Twenty carcinogens demonstrated no activity in this
assay. The positive and negative predictivity of this
assay for these 73 chemicals is 73% (24/33) and 50% (20/
40), respectively (Table3). Theaddition ofanS9fraction
was required in order to demonstrate a response for 10
of the 33 positive chemicals. Dependence or indepen-
dence ofexogenous metabolic activation did not appear
to berelated to sex/species ornumberofsites oftumors
induced by carcinogens. The 9 noncarcinogens (8-hy-
droxyquinoline, diallylphthalate, eugenol, C.I. AcidOr-
ange 10, phenol, propyl gallate, 2,6-toluenediamine,
stannous chloride, and chloroethanol) did not demon-
strate any clear differences in potency orpatterns, i.e.,
simple or complex aberrations, of clastogenesis when
compared with the carcinogens.
In relation to the SAL mutagenesis results, 4 ofthe
20 rodent carcinogens that were SAL positive did not
induce ABS. Of the 24 rodent carcinogens inactive in
the SAL assay, only8induced aberrationsinCHO cells.
These results do not strongly recommend the chromo-
some aberration assay as being complementary to the
SAL assay. Nine ofthe rodent noncarcinogens induced
aberrations (Table 3), and 3 of these were chemicals
that were also mutagenic inthe SAL, MOLY, and SCE
assays. Only 1 chemical, C.I. Acid Orange 10, induced
ABSastheonlypositiveresponse amongthefourmajor
STT (Table 1).
SCEs were induced by 32 ofthe 44 carcinogens; con-
versely, 16of29noncarcinogensalsoinduced SCEs (Ta-
ble 3). There were 3 carcinogens (benzene, DEHP, 11-
aminoundecanoic acid) forwhich SCE induction was the
only observed in vitro positive response; in all three
instances the chemical was active in the absence ofS9.
Inrelation tothe otherthree end points, the sensitivity
(73%)oftheCHO/SCE assaywasmostsimilartoMOLY
mutagenesis (70%) compared to Salmonella (45%) or
CHO/ABS (55%) responses (Table 3). However, while
the sensitivity ofthe CHO/SCE and MOLYassayswere
high, they both exhibited the lowest specificity (45%)
(Table 3). These assays alone or in combination do not
provideacomplementaryassayfortheSalmonellaassay
(8).
The results obtained with the four assays described
above did not show significant differences in individual
concordance with the rodent carcinogenicity results
since all of the end points showed approximately 60%
accuracy (Table 3). Further, there was no evidence of
complementarity among the four assays and no battery
or series of tests constructed from these end points
improved substantially on the overall performance of
the Salmonellaassay. However, since such alargenum-
ber of carcinogens were negative in all, or positive in
only one or two assays, there is a need to seek one or
more assays that may complement, for example, the
Salmonella assay. Complementarity could be demon-
strated by the detection ofmore carcinogens without a
concomitant increase in the number of noncarcinogens
detected as genotoxic. It seems reasonable to search
among available short-term in vivo assays for one or
more end points that can improve on the sensitivity of
the in vitro assays without having a negative effect on
the specificity (i.e., increasing the number offalse pos-
itives). We have begun to test the same 73 chemicals
in some in vivo assays for which we have developed
protocols that generate comparably reproducible re-
sults. While only asubset ofchemicals have beentested
thus far, and additional tests are currently in progress,
the results available to date are included in Table 2.
This table also presents limited results obtained with
some other in vitro assays.
Mutagenicity in Drosophila
Twenty-six ofthe 73 chemicals were treated for mu-
tagenicity in the sex-linked recessive lethal mutation
assay in Drosophila melanogaster (15) (Table 2). Only
4 chemicals induced mutations and all of these were
rodent carcinogens. Fifteen other rodent carcinogens
did not induce mutations in Drosophila. Thus, while the
positive predictivity and specificity of the assay were
high, the sensitivity ofthe assay is low. Three ofthe 4
chemicals positive in Drosophila were alsomutagenic in
Salmonella, but 9/26 other chemicals that were Salmo-
nella mutagens did not induce mutations in Drosophila.
Similarly, these 4 Drosophila mutagens were active in
the other STTs. However, the Drosophila assay is an
in vivo germ cell mutagenesis assay where effects are
observed only in the progeny and, therefore, may not
be appropriate as a predictor of carcinogenicity.
In Vivo Cytogenetic Effects-Mouse Bone
Marrow
Mouse bone marrow cytogenetics results are cur-
rentlyavailableforonly 16ofthe73chemicalsforeffects
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on chromosome aberrations or sister chromatid ex-
change induction in B6C3F1 mice (17) (Table 2). Eight
ofthese chemicals demonstrated carcinogenic activity,
and 8 were noncarcinogenic. If an effect on either end
point (ABS or SCE) is considered, 7 ofthe carcinogens
and 4 of the noncarcinogens were correctly identified
(accuracy = 69%). Six of the 8 carcinogens and 4 of
the8noncarcinogensinduced SCEs (accuracy = 63%).
The only carcinogen not identified by either assay was
di(2-ethylhexyl)phthalate (DEHP). With the exception
ofcaprolactam, the othernoncarcinogens demonstrated
evidence of in vitro genetic toxicity, although 1,2-di-
chlorobenzene and benzoin were positive only in the
MOLY assay and CHO/SCE end points.
Two chemicals showing clear evidence ofin vitro ge-
netic toxicity but that were not rodent carcinogens (2-
chloroethanol and 8-hydroxyquinoline) did not induce
cytogenetic effects in vivo, suggesting that in vivo cy-
togenetics assay might serve to discriminate between
invitro genotoxic carcinogens and noncarcinogens that
exhibit in vitro genetic toxicity. Phenol induced cyto-
genetic effects both in vitro and in vivo but was not
tumorigenic in rodents.
Unscheduled DNA Synthesis (UDS) In
Vitro
The unscheduled DNA synthesis (UDS) in rat (F344)
liverhepatocytes assay (16) was performed on44 chem-
icals (Table 2). The assay detected 6 ofthe 30 carcino-
gens and 1 (H.C. Blue 2) of the 14 noncarcinogens in-
duced apositiveresponse. Twentyofthe 30carcinogens
induced liver tumors in either rats or mice. The assay
detected 4 (4,4'-methylenedianiline 2 HCl, C.I. Dis-
perse Yellow 3, C.I. Solvent Yellow 14, and selenium
sulfide) ofthe9carcinogensthatinducedhepatictumors
in rats and only 1 (H.C. Blue 1) of the 10 mouse he-
patocarcinogens. The sixth rodent carcinogen detected
was 1,2-dibromoethane, which induced tumors at mul-
tiple sites in both sex/species, but did not induce liver
tumors. The 5 hepatocarcinogens that were detected
areeitherprimaryamines orcapable ofbeingconverted
into primary amines; however, 6 other carcinogens that
are primary amines did not induce a positive response.
The 6 carcinogens positive in the UDS assay were also
positive in at least three other in vitro end points, but
9 other carcinogens that induced responses in at least
three end points did not induce a response in the UDS
assay.
In Vivo-In Vitro UDS
Fifteen chemicals have been evaluated in the UDS
assaythat measures unscheduled DNAsynthesis incul-
turedhepatocytes derived fromanimals exposed to test
chemicals (18) (Table 2). All except H.C. Blue 2 were
rodentcarcinogens and 13ofthe 14inducedlivertumors
in either or both rodent species. None ofthe chemicals
induced a UDS response, even though 12 ofthe 13 he-
patocarcinogens were tested in the same sex/species in
which the chemicals were tumorigenic. The same 15
chemicals were also tested in the in vitro UDS assay,
and with the exception of 4 (4,4'-methylenediani-
line 2HCI, H.C. Blue 1, H.C. Blue 2, and selenium
sulfide) did not induce in vitro unscheduled DNA syn-
thesis.
Mammalian Cell Transformation In Vitro
Four different mammalian cell transformation assays
have been evaluated by the NTP (19-22), but only 12
chemicals from the group of 73 have been tested in all
four systems (Table 2). All 6 ofthe carcinogens tested
induced positive responses, and with the exception of
DEHP, they were active in all four systems. Transfor-
mation was the only in vitro STT end point for which
the carcinogen reserpine induced a positive response.
However, the 6 noncarcinogens tested also induced a
responseinatleastonesystem. Thedataareinsufficient
to adequately evaluate these assays at this time and
more noncarcinogens and nongenotoxic carcinogens
need to be included for comparative evaluation.
Discussion
While many unanswered questions remain, the re-
sults of this evaluation carry several important impli-
cations for the use of short-tern tests to identify po-
tential carcinogens. The overall concordance among
results in the four principalgenetictoxicity tests shows
thattheassayscanbeusedreliablytoidentifygenotoxic
chemicals. For 59/73 (81%) ofthe chemicals, the genetic
toxicity results were in agreement for 4/4 or 3/4 assays
used. For 34 of the 59 (58%), all four end points were
in agreement. While conclusions based on the limited
number ofchemicals tested in in vivo systems must be
considered preliminary, the presence or absence of an
in vivo effect appears to be highly infornative. The
limited use of short-term, whole animal assays is nec-
essary, particularly for chemicals that fail to induce ef-
fects in vitro, e.g., benzene, or where the substance
cannot be adequately metabolized or converted to the
same DNA or chromatin-reactive intermediates that
may be generated in the whole animal. Conversely, it
mayalsobe necessarytoutilize invivoassaysforchem-
icals that show clear evidence ofgenetic toxicity in vi-
tro, since disposition ormetabolism ofchemicals invivo
can also mitigate against the induction of observable
genetic toxicity in vivo.
The choice ofthe available and well-characterized in
vitro short-term test systems depends upon the specific
answers needed. Ifthe primary goal is the prospective
identification of potential carcinogens, the Salmonella
mutagenesisassayhassomeadvantagesovertheothers
in reproducibility and reliability oftechnical execution,
relatively low cost, and short duration. The evaluation
ofthis data set of73 indicates that none ofthe other in
vitroendpoints, eithersinglyorincombinationincrease
the overall concordance with the rodent results to a
degree significantly greater than the Salmonella assay
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alone. WhiletheSalmonellaassayproducedonlyasingle
positive response that was discordant with the other
STT assays, there were 23/73 chemicals that were neg-
ative in Salmonella and positive in at least two of the
other end points; 11 ofthese 23results werediscordant
withthe MOLYmutagenesis andCHO/SCE endpoints,
and 6 ofthe 11 were not rodent carcinogens.
Ourevaluation, therefore, suggeststhatthepotential
genetictoxicity ofmostchemicals canbedetectedusing
the Salmonella mutagenesis assay. No other single in
vitro assay appears tobe sufficiently complementary to
SAL, to the point where it is cost effective to perform
the additional assay. However, several of the assays,
e.g., MOLY or CHO/ABS or SCE, could be useful in a
confirnatory capacity. A conservative in itro assay
such as the UDS assay or the in vivo Drosophila re-
cessive lethal assay can also prove useful for confir-
matorypurposes, sinceafalsepositiveresponseinthese
assays is very unusual. The verification of the actual
value ofthe invivo assays andthefinalchoice ofassays
must await the results oftesting the remainder ofthe
73 chemicals in these systems.
Therefore, it appears that clear evidence of;muta-
genicity, that is, a statistically significant effect in at
least one strain of Salmonella, indicates a high proba-
bility of potential tumorigenicity in rodents. It is not,
however, a certain indicator oftumorigenicity, since 4
chemicals that were not carcinogenic were mutagenic
inSalmonella(8-hydroxyquinoline, 2-chloroethanol, 2,6-
toluenediamine, andH.C. Blue2). However, sincethese
4 chemicals were also active in three other invitro end
points, these are excellent candidates for future in-
depth animal and in vitro studies, in which chemical
disposition, pharnacokinetics, extent ofDNA binding,
identification of DNA adducts, etc., can be elucidated.
Conversely, the absence of evidence ofgenetic tox-
icity in SAL or other in vitro tests does not carry any
clearimplications as to the probable noncarcinogenicity
ofthe chemical. Six substances thatinduce neoplasiain
rodents did not induce any response in four end points
(SAL, MOLY, CHO/SCE, and ABS), nor did 10 non-
carcinogens. Therefore, prospectively, such chemicals
could not be distinguished on the basis of any of the
tests used in this study.
The classification of rodent tumorigenicity is ex-
pressed on an individual sex/species basis as either
clear, some, ornoevidenceofcarcinogenicactivity. This
distinction is based principally on the statistical mag-
nitude ofthe response in the individualgroups. Forthe
purpose ofthisevaluation, the sex/species patterns, tu-
mor sites and types, and malignancy were also consid-
ered. Twelve of the 44 carcnogens were carcnogenic
in both sexes of both species and 8 of the 12 induced
responses in at least three in vitro systems. Of the
remaining 4, benzene induced chromosome aberrations
in mouse bone marrow cells when tested in vivo. Di(2-
ethylhexyl)phthalate, which produced liver tumors, in-
duced a response only in SCEs in CHO cells. Both po-
lybrominatedbiphenyl(PBBmixture)and2,3,7,8-tetra-
chlorodibenzo-p-dioxin (TCDD) have been shown to
demonstrate tumor promotion activity in the two-stage
expeximental model in rat liver (23,24). However, it is
not possible to infer retrospectively tumor promotion
activity forthese chemicals on the basis ofthe two sex/
species results of chronic exposure. Both substances
were tumorigenic in the absence of any experimental
initiator chemical and in addition to hepatocellular neo-
plasia, the PBB mixture induced cholangiocarcinomas
in female rats and TCDD induced thyroid neoplasia in
male rats and female mice. These results suggest that
the absence ofa positive response in assays for genetic
toxicity cannot be used to infer noncarcinogenicity and
that the distinction between initiating carcinogens and
tumor promoters is possible only in the context oftwo-
stage experimental designs. Previous efforts to distin-
guish and relate these various effects as the basis of
classification ofchemicals asgenotoxicornongenotoxic,
epigenetic, initiator, promoter, etc. (e.g., 25), have not
achieved a workable acceptance. A detailed discussion
ofthe differences in these classifications is not possible
here, but two principal objections are that many chem-
icalsmaydemonstrate morethan onepropertydepend-
ingonthe circumstances and duration ofexposure, and
that classifications that are mutually exclusive or de-
pend upon the absence of an observed effect are not
useful.
It should be emphasized that the tumorigenicity re-
sults used inthis evaluation are aproduct ofdosetimes
duration ofexposure. Although interim sacrifices were
not routinely conducted, the interim death autopsies
and incidence oftumorinduction atthe end ofthe stud-
ies suggests that most ofthe substances required pro-
tracted exposures at or near the maximum tolerated
dose (MTD) in ordertodemonstrate carcinogenic activ-
ity. These facts must be contrasted with the relatively
limited number of chemicals shown to be tumorigenic
with short latent periods following one or a few acute
exposures. The majority ofthese latter substances are
direct-acting alkylating agents or are reaily metabo-
lized to electrophilic intermediates that are highly re-
active with DNA (26). The majority ofsuch substances
demonstrateclearevidence ofgenetictoxicityandhave
been used in the development ofmost genetic toxicity
assays (1). Such substances often demonstrate trans-
sex/species carcinogenicity. Themajority ofsubstances
showing the trans-sex/species carcinogenicity in the 2-
year rodent studies also showed clear evidence of ge-
netictoxicity, but, asnoted, thereweresomeimportant
exceptions. It is possible that the disposition and me-
tabolism ofchemicals is animportant mitigatingfactor,
even for chemicals that are genotoxic. Such chemicals
mustgaineffective access to DNAincellsintheanimal
in order to induce genotypic change and this may also
be influenced by the dose times duration. However,
since there is such a large number of substances that
are carcinogenic but do not demonstrate eitherin vitro
or in vivo genetic toxicity using the tests described
here, it is clear that other modes ofchemically related
carcnogenesis are possible. Evidence from avarietyof
sources indicate that many chemicals, including those
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thatdemonstrate tumorpromotionactivity, bringabout
many alterations in cells that involve nonmutagenic
genotypic change, or that are mutagenic at the chro-
mosome level by altering the number of chromosomes
(27). Such alterations may be related to processes oc-
curringindifferentiationandgrowthorthechromosome
segregation apparatusthatinvolveheritablephenotypic
changes. It may, therefore, be possible to distinguish
the clearly genotoxic chemicals, including aneuploidi-
gens, that have the capacity to induce genotypic her-
itable change from those that cause adaptive cellular
events that lead to heritable phenotypic change. The
currently available in vitro and in vivo genetic toxicity
assays can be used effectively to prospectively identify
chemicals that have a high probability of acting as in-
ductive carcinogens. The limitations of current assays
are that they are unable to distinguish chemicals that
may act as adaptive carcinogens from chemicals that
are not genotoxic and not carcinogenic. Development of
assaysthat caneffectively accomplish the latterdepend
upon improving our understanding of the processes of
differentiation and growth.
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